Trial Profile
A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs EQ 101 (Primary)
- Indications Adult T-cell leukaemia-lymphoma; Alopecia areata; Cutaneous T-cell lymphoma; Large granular lymphocytic leukaemia; T-cell leukaemia
- Focus Adverse reactions
- Sponsors Bioniz
- 12 May 2018 Status changed from active, no longer recruiting to completed.
- 01 May 2018 According to a Bioniz media release, full results will be at the 2018 International Investigative Dermatology Meeting.
- 01 May 2018 Results presented in a Bioniz Media Release.